from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1146/mmpL13b

LFCtreatmentdescriptionclass of inhibitor

0.162

Amikacinug/mL Amikacintranslation

-0.512

Cap5-10ug/mL Capreomycintranslation

0.461

Rox10-50 ug/mL Roxithromycintranslation

1.119

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.449

Rif0.2-5ug/mL Rifampicintranscription

0.381

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.561

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.396

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.043

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.143

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.570

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.252

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.341

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.436

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.309

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.512

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.228

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.753

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.142

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.678

KCN5-20 ug/mL Potassium cyaniderespiration

-0.331

NaN30.2-2 mM Sodium aziderespiration

-0.947

Nigericin50 uM Nigericinrespiration

-0.268

TRC10-150 ug/mL Triclosanrespiration

0.110

TRZ10-25 ug/mL Thioridazinerespiration

0.371

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.560

menadione6-10 ug/mL Menadionerespiration

-0.445

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.107

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.591

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.612

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.743

NRP_1Non-replicating persistence stage 1dosRassociated

-0.816

Amp0.2mg/mL AmpicillincellWall

-0.024

Cephalexin20-100 ug/mL CephalexincellWall

0.821

Cerulenin0.32-5 ug/mL CerulenincellWall

1.800

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.090

EMB10-20 ug/mL EthambutolcellWall

0.672

Eta12-40 ug/mL EthionamidecellWall

0.720

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.171

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.490

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.535

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

BZA0.12 mg/mL BenzamidearomaticAmides

1.264

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.201

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.700

H2O24 mM hydrogen peroxideDNAdamaging

-0.172

Levo10 ug/mL LevofloxacinDNAdamaging

1.208

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.695

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.052

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.225

UVUV-irradiationDNAdamaging

-0.035

ARP41-4 ug/mL Antitubercular compound ARP4?

0.117

Antimycin12.5-50 ug/mL Antimycin A?

-0.165

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.137

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.279

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.422

PA8240.2-2 ug/mL PA-824?

-0.841

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.377

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.407

Verapamil50 uM Verapamil?

-0.428

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.480

methoxatin10-20 ug/mL Methoxatin?